Literature DB >> 10487580

Noninvasive patient fixation for extracranial stereotactic radiotherapy.

F Lohr1, J Debus, C Frank, K Herfarth, O Pastyr, B Rhein, M L Bahner, W Schlegel, M Wannenmacher.   

Abstract

PURPOSE: To evaluate the setup accuracy that can be achieved with a novel noninvasive patient fixation technique based on a body cast attached to a recently developed stereotactic body frame during fractionated extracranial stereotactic radiotherapy. METHODS AND MATERIALS: Thirty-one CT studies (> or = 20 slices, thickness: 3 mm) from 5 patients who were immobilized in a body cast attached to a stereotactic body frame for treatment of paramedullary tumors in the thoracic or lumbar spine were evaluated with respect to setup accuracy. The immobilization device consisted of a custom-made wrap-around body cast that extended from the neck to the thighs and a separate head mask, both made from Scotchcast. Each CT study was performed immediately before or after every second or third actual treatment fraction without repositioning the patient between CT and treatment. The stereotactic localization system was mounted and the isocenter as initially located stereotactically was marked with fiducials for each CT study. Deviation of the treated isocenter as compared to the planned position was measured in all three dimensions.
RESULTS: The immobilization device can be easily handled, attached to and removed from the stereotactic frame and thus enables treatment of multiple patients with the same stereotactic frame each day. Mean patient movements of 1.6 mm+/-1.2 mm (laterolateral [LL]), 1.4 mm+/-1.0 mm (anterior-posterior [AP]), 2.3 mm+/-1.3 mm (transversal vectorial error [VE]) and < slice thickness = 3 mm (craniocaudal [CC]) were recorded for the targets in the thoracic spine and 1.4 mm+/-1.0 mm (LL), 1.2 mm+/-0.7 mm (AP), 1.8 mm+/-1.2 mm (VE), and < 3 mm (CC) for the lumbar spine. The worst case deviation was 3.9 mm for the first patient with the target in the thoracic spine (in the LL direction). Combining those numbers (mean transversal VE for both locations and maximum CC error of 3 mm), the mean three-dimensional vectorial patient movement and thus the mean overall accuracy can be safely estimated to be < or = 3.6 mm.
CONCLUSION: The presented combination of a body cast and head mask system in a rigid stereotactic body frame ensures reliable noninvasive patient fixation for fractionated extracranial stereotactic radiotherapy and may enable dose escalation for less radioresponsive tumors that are near the spinal cord or otherwise critically located while minimizing the risk of late sequelae.

Entities:  

Mesh:

Year:  1999        PMID: 10487580     DOI: 10.1016/s0360-3016(99)00190-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

Review 1.  [Radiotherapy of hepatic metastases].

Authors:  S E Combs; K K Herfarth; D Habermehl; J Debus
Journal:  Chirurg       Date:  2010-06       Impact factor: 0.955

Review 2.  The evolving role of stereotactic radiosurgery and stereotactic radiation therapy for patients with spine tumors.

Authors:  Jack P Rock; Samuel Ryu; Fang-Fang Yin; Faye Schreiber; Muwaffak Abdulhak
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

Review 3.  Radiosurgery for spinal malignant tumors.

Authors:  Berndt Wowra; Alexander Muacevic; Stefan Zausinger; Jörg-Christian Tonn
Journal:  Dtsch Arztebl Int       Date:  2009-02-13       Impact factor: 5.594

Review 4.  Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Authors:  Anna O Simeonova; Katharina Fleckenstein; Hansjörg Wertz; Anian Frauenfeld; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-03

5.  Intramedullary Spinal Cord Tumors.

Authors:  Daniel C. Bowers; Bradley E. Weprin
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

6.  Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results.

Authors:  Carmen Llacer-Moscardo; Olivier Riou; David Azria; Ludovic Bedos; Norbert Ailleres; Francois Quenet; Philippe Rouanet; Marc Ychou; Pascal Fenoglietto
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-05

7.  Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression.

Authors:  Cynthia L Eccles; Laura A Dawson; Joanne L Moseley; Kristy K Brock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

8.  Perk Station--Percutaneous surgery training and performance measurement platform.

Authors:  Siddharth Vikal; Paweena U-Thainual; John A Carrino; Iulian Iordachita; Gregory S Fischer; Gabor Fichtinger
Journal:  Comput Med Imaging Graph       Date:  2009-06-17       Impact factor: 4.790

9.  Analysis of fiducial markers used for on-line verification in the external-beam radiotherapy of patients with cranial tumours.

Authors:  R Ma Cañón; I Azinovic; M Lobato; J Navarro; J Rebollo
Journal:  Clin Transl Oncol       Date:  2007-08       Impact factor: 3.405

10.  Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study.

Authors:  Maria Marsico; Tommaso Gabbani; Lorenzo Livi; Maria Rosa Biagini; Andrea Galli
Journal:  World J Hepatol       Date:  2016-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.